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An outbreak of community-acquired methicillin-resist-
ant Staphylococcus aureus occurred among members and
close contacts of a soccer team. Typing of the isolates
showed the outbreak was caused by the well-known
European ST80-IV strain. To our knowledge, this is the first
report of an outbreak of this strain among members of a
sports team.
Community-acquired methicillin-resistant Staphy-lococcus aureus (CA-MRSA) is emerging as a cause
of skin and soft tissue infections. CA-MRSA differs from
hospital-associated MRSA in several ways (1). Most CA-
MRSA isolates contain the virulence factor Panton-
Valentine leukocidin (PVL) and carry staphylococcal
cassette chromosome (SCC) mec type IV or V (2). In the
Netherlands the prevalence of MRSA is still low (≈1%)
(3), and ≈10 % of all MRSA isolates carry the genes for
PVL (4).
Several reports have been published about CA-MRSA
outbreaks among sports team members, communities, pris-
oners, men who have sex with men, military personnel,
and drug users (5). Most of these cases occurred in the
United States and were caused by USA300 MRSA
sequence type (ST) 8 strains. In Europe the ST80-MRSA-
IV strain is common (4,6) but has not been reported to
have caused an outbreak in sports teams. A CA-MRSA
outbreak in a British rugby team has been reported (7), but
given the reported phage type, this strain was not ST80-
MRSA-IV. So far, CA-MRSA outbreaks have usually
occurred in intensive contact sports such as football
(8–10), rugby (7), and wrestling (11). 
We report on the results of the screening that was con-
ducted after MRSA was isolated from a boil on a Dutch
soccer player and, subsequently, soft-tissue infections
developed on other members of the soccer team. 
The Study
Starting in June 2005, several players of a Dutch soccer
team, consisting of ≈35 members, noted soft-tissue infec-
tions. In October 2005, the municipal health service
received a report of a patient, a member of this soccer
team, who had been hospitalized for an abscess resulting
from MRSA. Other members of the team had skin infec-
tions as well, and screening was started. 
A case was defined as a patient who had a culture-con-
firmed MRSA infection during the outbreak period
October 2005 through January 2006. Healthcare staff
obtained specimens by swabbing the patients’ nose, throat,
or wound. A total of 56 persons were screened: 42 mem-
bers of the soccer club and 14 of their roommates. The 42
members consisted of soccer players, coaches, and people
who used the same training facilities, locker room, and
showers. The roommates screened were all those who
lived with an MRSA-positive player and those who lived
with an MRSA-negative player but had skin infections. Of
the 56 persons screened, we identified an MRSA infection
in 11 persons: 9 soccer players and 2 roommates (Table).
Most infections lasted for several weeks. For all players
who had soft tissue infections, MRSA was diagnosed.
Among those in whom infections did not develop, no car-
riage of MRSA was found. One roommate had an abscess
in the armpit, but the soccer player she lived with was
MRSA negative. The mean age of the patients was 31
years (range 18–43). No histories of travel were reported. 
To prevent further MRSA transmission, on October 28
the soccer club was instructed to increase hand hygiene,
not share personal items, use liquid soap and disposable
towels, put a towel on the bench before sitting, increase
frequency of cleaning the facilities, and provide more ven-
tilation to the locker room and showers. All patients were
treated with cotrimoxazole for 1 week or, if needed, longer
until wound infections were healed. Seven patients
remained MRSA positive or had recurring wound infec-
tions. Perineum cultures from 3 patients showed carriage
of MRSA in the gastrointestinal tract, and rifampicin was
added to cotrimoxazole for 1 week or, if needed, longer
until wounds were healed. Patients were advised to use
clean bedding and clothing every day. Furthermore,
patients used chlorohexidine, gluconate scrub, povidone
iodine, and mupirocin ointment for 5 days. A patient was
declared MRSA free after 3 cultures, taken at 1-week inter-
vals, were MRSA negative. One patient, who also had
eczema, remained MRSA positive. 
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In November 2005, MRSA was isolated from a 33-
year-old soccer player with a boil, who was a member of a
neighboring team. This soccer player had competed
against the team with the MRSA-positive players on
October 8, before MRSA-positive results were known and
hygiene measures recommended. Immediately, this play-
er’s team was screened for MRSA; all other players were
MRSA negative. The MRSA isolate from this player was
included in the analysis. 
To characterize the MRSA strains, the following typing
methods were used: pulsed-field gel electrophoresis
(PFGE), staphylococcal protein A (spa) typing, multilocus
sequence typing, SCCmec typing, and PCR of PVL genes
(LukS-LukF). All MRSA isolates were identical and iden-
tified as the European CA-MRSA ST80-MRSA-IV strain.
All strains were PFGE type 28 (according to the Dutch
PFGE classification system), spa type t044, ST80,
SCCmec IV, and PVL positive. All MRSA isolates had
identical susceptibility patterns; they were resistant to
oxacillin (and thus to all β-lactam antimicrobial drugs),
tetracycline, and fusidic acid. They were susceptible to
rifampicin, ciprofloxacin, gentamicin, erythromycin, clin-
damycin, vancomycin, teicoplanin, and cotrimoxazole. 
Conclusions
This study shows transmission of the CA-MRSA ST80-
IV strain among members of a Dutch soccer team.
Transmission apparently occurred not only between mem-
bers of this team but also to a competing soccer team.
Transmission of the USA300 strain between members of
different teams was previously described for football
teams (8). We cannot rule out the possibility of an inde-
pendent colonization of the ST80-MRSA-IV strain in the
competing team, but the 2 teams competed against each
other during the period when the first symptoms were
noted by members of the first team. Because soccer
involves much less contact than football, rugby, or
wrestling, MRSA transmission may not necessarily have
been caused by skin-to-skin contact but could also have
occurred by sharing equipment or personal items. This
possibility has also been suggested in a report about a CA-
MRSA outbreak among sports participants (12).
To our knowledge, this is the first report of an outbreak
of the CA-MRSA ST80-IV strain in a sports team. As with
the USA300 strain, more outbreaks of CA-MRSA ST80-
IV are likely. Therefore, to identify and control an outbreak
as early as possible, sports physicians and coaching staff
should be alerted and informed about CA-MRSA. 
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